A carregar...
Synergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence
Ixabepilone demonstrates marked synergistic activity in combination with capecitabine, which served as the rationale for the evaluation of this combination in the clinic. Ixabepilone plus capecitabine is currently approved for patients with locally advanced or metastatic breast cancer (MBC) progress...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3126033/ https://ncbi.nlm.nih.gov/pubmed/21789152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834010386402 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|